Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 2, 2015, Pages 191-200

  Kitamoto, Takumi ^a   Suematsu, Sachiko ^a   Matsuzawa, Yoko ^a   Saito, Jun ^a   Omura, Masao ^a   Nishikawa, Tetsuo ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Aldosterone producing adenoma; KCNJ5; Left ventricular hypertrophy

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; POTASSIUM ION; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; MESSENGER RNA;

ADRENALECTOMY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATP1A1 GENE; ATP2B3 GENE; CACNA1D GENE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIMARY HYPERALDOSTERONISM; PULSE WAVE; RADIOIMMUNOASSAY; ADENOMA; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION (PROCESS);

ADENOMA; ALDOSTERONE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84923224529     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.24455     Document Type: Article

References (50)

1. Choi, M., U.I. Scholl, P. Yue, P. Bjorklund, B. Zhao, C. Nelson-Williams, W. Ji, Y. Cho, A. Patel, C.J. Men, E. Lolis, M.V. Wisgerhof, D.S. Geller, S. Mane, P. Hellman, G. Westin, G. Akerstrom, W. Wang, T. Carling, and R.P. Lifton, K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science, 2011. 331(6018): p. 768-72
2. Beuschlein, F., S. Boulkroun, A. Osswald, T. Wieland, H.N. Nielsen, U.D. Lichtenauer, D. Penton, V.R. Schack, L. Amar, E. Fischer, A. Walther, P. Tauber, T. Schwarzmayr, S. Diener, E. Graf, B. Allolio, B. Samson-Couterie, A. Benecke, M. Quinkler, F. Fallo, P.F. Plouin, F. Mantero, T. Meitinger, P. Mulatero, X. Jeunemaitre, R. Warth, B. Vilsen, M.C. Zennaro, T.M. Strom, and M. Reincke, Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone- producing adenomas and secondary hypertension. Nat Genet, 2013. 45(4): p. 440-4, 444e1-2
3. Scholl, U.I., G. Goh, G. Stolting, R.C. de Oliveira, M. Choi, J.D. Overton, A.L. Fonseca, R. Korah, L.F. Starker, J.W. Kunstman, M.L. Prasad, E.A. Hartung, N. Mauras, M.R. Benson, T. Brady, J.R. Shapiro, E. Loring, C. Nelson- Williams, S.K. Libutti, S. Mane, P. Hellman, G. Westin, G. Akerstrom, P. Bjorklund, T. Carling, C. Fahlke, P. Hidalgo, and R.P. Lifton, Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet, 2013. 45(9): p. 1050-4
4. Matsuzawa Y., Kitamoto T, Suematsu S, Saito J, Omura M and Nishikawa T, Steroidogenic Activity of Aldosterone- Producing Adenoma with and without KCNJ5 Gene Mutations, Comparing with That in Each Adherent Normal Tissue. J Endocrinol Diab, 2014. 1(1): p. 1-6
5. Taguchi, R., M. Yamada, Y. Nakajima, T. Satoh, K. Hashimoto, N. Shibusawa, A. Ozawa, S. Okada, N. Rokutanda, D. Takata, Y. Koibuchi, J. Horiguchi, T. Oyama, I. Takeyoshi, and M. Mori, Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone- producing adenomas. J Clin Endocrinol Metab, 2012. 97(4): p. 1311-9
6. Rossi, G.P., A. Sacchetto, P. Visentin, C. Canali, G.R. Graniero, P. Palatini, and A.C. Pessina, Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension, 1996. 27(5): p. 1039-45
7. Rossi, G.P., V. Di Bello, C. Ganzaroli, A. Sacchetto, M. Cesari, A. Bertini, D. Giorgi, R. Scognamiglio, M. Mariani, and A.C. Pessina, Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension, 2002. 40(1): p. 23-7
8. Catena, C., G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, and L.A. Sechi, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med, 2008. 168(1): p. 80-5
9. Catena, C., G.L. Colussi, L. Marzano, and L.A. Sechi, Predictive factors of left ventricular mass changes after treatment of primary aldosteronism. Horm Metab Res, 2012. 44(3): p. 188-93
10. Lin, Y.H., L.Y. Lin, A. Chen, X.M. Wu, J.K. Lee, T.C. Su, V.C. Wu, S.C. Chueh, W.C. Lin, M.T. Lo, P.C. Wang, Y.L. Ho, and K.D. Wu, Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis, 2012. 221(1): p. 154-9
11. Catena, C., G. Colussi, R. Lapenna, E. Nadalini, A. Chiuch, P. Gianfagna, and L.A. Sechi, Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension, 2007. 50(5): p. 911-8
12. Rossi, G.P., M. Cesari, C. Cuspidi, G. Maiolino, M.V. Cicala, V. Bisogni, F. Mantero, and A.C. Pessina, Longterm control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension, 2013. 62(1): p. 62-9
13. Ohkubo, T., Y. Imai, I. Tsuji, K. Nagai, N. Watanabe, N. Minami, J. Kato, N. Kikuchi, A. Nishiyama, A. Aihara, M. Sekino, H. Satoh, and S. Hisamichi, Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens, 1997. 10(11): p. 1201-7
14. Seino Y, N.K., Tajima N, Kadowaki T, Kashiwagi A, et al., Committee report on the classification and the diagnostic criteria of diabetes mellitus. Diabetes (Tounyoubyo) 2012. 55: p. 485-504
15. Teramoto, T., J. Sasaki, S. Ishibashi, S. Birou, H. Daida, S. Dohi, G. Egusa, T. Hiro, K. Hirobe, M. Iida, S. Kihara, M. Kinoshita, C. Maruyama, T. Ohta, T. Okamura, S. Yamashita, M. Yokode, K. Yokote, and S. Japan Atherosclerosis, Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb, 2013. 20(6): p. 517-23
16. Nishikawa, T., M. Omura, F. Satoh, H. Shibata, K. Takahashi, N. Tamura, and A. Tanabe, Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J, 2011. 58(9): p. 711- 21
17. Omura, M., H. Sasano, T. Fujiwara, K. Yamaguchi, and T. Nishikawa, Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism, 2002. 51(3): p. 350-5
18. Omura, M. and T. Nishikawa, [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism]. Rinsho Byori, 2006. 54(11): p. 1157-63
19. Omura, M., H. Sasano, J. Saito, K. Yamaguchi, Y. Kakuta, and T. Nishikawa, Clinical characteristics of aldosterone- producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res, 2006. 29(11): p. 883-9
20. Sakuma, I., S. Suematsu, Y. Matsuzawa, J. Saito, M. Omura, T. Maekawa, Y. Nakamura, H. Sasano, and T. Nishikawa, Characterization of steroidogenic enzyme expression in aldosterone-producing adenoma: a comparison with various human adrenal tumors. Endocr J, 2013. 60(3): p. 329-36
21. Devereux, R.B., D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, and N. Reichek, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol, 1986. 57(6): p. 450-8
22. Devereux, R.B., Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension, 1987. 9(2 Pt 2): p. II19-26
23. Yamashina, A., H. Tomiyama, K. Takeda, H. Tsuda, T. Arai, K. Hirose, Y. Koji, S. Hori, and Y. Yamamoto, Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res, 2002. 25(3): p. 359-64
24. Bots, M.L., A.W. Hoes, P.J. Koudstaal, A. Hofman, and D.E. Grobbee, Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997. 96(5): p. 1432-7
25. O'Leary, D.H., J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson, Jr., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999. 340(1): p. 14-22
26. Irie, Y., N. Katakami, H. Kaneto, R. Kasami, S. Sumitsuji, K. Yamasaki, K. Tachibana, T. Kuroda, K. Sakamoto, Y. Umayahara, Y. Ueda, K. Kosugi, and I. Shimomura, Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease. Atherosclerosis, 2012. 221(2): p. 438-44
27. Nishikawa, T., S. Suematsu, J. Saito, A. Soyama, H. Ito, T. Kino, and G. Chrousos, Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol, 2005. 96(3-4): p. 309-16
28. Nishikawa, T., Y. Matsuzawa, S. Suematsu, J. Saito, M. Omura, and T. Kino, Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells. Arzneimittelforschung, 2010. 60(7): p. 445-51
29. Williams, T.A., S. Monticone, V.R. Schack, J. Stindl, J. Burrello, F. Buffolo, L. Annaratone, I. Castellano, F. Beuschlein, M. Reincke, B. Lucatello, V. Ronconi, F. Fallo, G. Bernini, M. Maccario, G. Giacchetti, F. Veglio, R. Warth, B. Vilsen, and P. Mulatero, Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension, 2014. 63(1): p. 188-95
30. Akerstrom, T., J. Crona, A. Delgado Verdugo, L.F. Starker, K. Cupisti, H.S. Willenberg, W.T. Knoefel, W. Saeger, A. Feller, J. Ip, P. Soon, M. Anlauf, P.F. Alesina, K.W. Schmid, M. Decaussin, P. Levillain, B. Wangberg, J.L. Peix, B. Robinson, J. Zedenius, M. Backdahl, S. Caramuta, K.A. Iwen, J. Botling, P. Stalberg, J.L. Kraimps, H. Dralle, P. Hellman, S. Sidhu, G. Westin, H. Lehnert, M.K. Walz, G. Akerstrom, T. Carling, M. Choi, R.P. Lifton, and P. Bjorklund, Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One, 2012. 7(7): p. e41926
31. Azizan, E.A., M. Murthy, M. Stowasser, R. Gordon, B. Kowalski, S. Xu, M.J. Brown, and K.M. O'Shaughnessy, Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension, 2012. 59(3): p. 587-91
32. Boulkroun, S., F. Beuschlein, G.P. Rossi, J.F. Golib-Dzib, E. Fischer, L. Amar, P. Mulatero, B. Samson-Couterie, S. Hahner, M. Quinkler, F. Fallo, C. Letizia, B. Allolio, G. Ceolotto, M.V. Cicala, K. Lang, H. Lefebvre, L. Lenzini, C. Maniero, S. Monticone, M. Perrocheau, C. Pilon, P.F. Plouin, N. Rayes, T.M. Seccia, F. Veglio, T.A. Williams, L. Zinnamosca, F. Mantero, A. Benecke, X. Jeunemaitre, M. Reincke, and M.C. Zennaro, Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension, 2012. 59(3): p. 592-8
33. Nishikawa, T., J. Saito, and M. Omura, Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J, 2007. 54(4): p. 487-95
34. Young, W.F., A.W. Stanson, G.B. Thompson, C.S. Grant, D.R. Farley, and J.A. van Heerden, Role for adrenal venous sampling in primary aldosteronism. Surgery, 2004. 136(6): p. 1227-35
35. Lewington, S., R. Clarke, N. Qizilbash, R. Peto, and R. Collins, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002. 360(9349): p. 1903-13
36. Funder, J.W., The role of aldosterone and mineralocorticoid receptors in cardiovascular disease. Am J Cardiovasc Drugs, 2007. 7(3): p. 151-7
37. Cuspidi, C., S. Meani, C. Sala, C. Valerio, F. Negri, and G. Mancia, Age related prevalence of severe left ventricular hypertrophy in essential hypertension: echocardiographic findings from the ETODH study. Blood Press, 2012. 21(3): p. 139-45
38. Milliez, P., X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, and J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol, 2005. 45(8): p. 1243-8
39. Savage, D.D., D. Levy, A.L. Dannenberg, R.J. Garrison, and W.P. Castelli, Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am J Cardiol, 1990. 65(5): p. 371-6
40. McQuarrie, E.P., E.M. Freel, P.B. Mark, R. Fraser, R.K. Patel, H.G. Dargie, J.M. Connell, and A.G. Jardine, Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease. Clin Sci (Lond), 2012. 123(5): p. 285-94
41. Catena, C., G. Colussi, M. Valeri, and L.A. Sechi, Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels. Am J Hypertens, 2013. 26(1): p. 111-7
42. Pouleur, A.C., H. Uno, M.F. Prescott, A. Desai, E. Appelbaum, V. Lukashevich, B.A. Smith, B. Dahlof, and S.D. Solomon, Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension. J Renin Angiotensin Aldosterone Syst, 2011. 12(4): p. 483-90
43. Rossi, G.P., A. Sacchetto, E. Pavan, P. Palatini, G.R. Graniero, C. Canali, and A.C. Pessina, Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation, 1997. 95(6): p. 1471-8
44. Shigematsu, Y., M. Hamada, H. Okayama, Y. Hara, Y. Hayashi, K. Kodama, K. Kohara, and K. Hiwada, Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension, 1997. 29(3): p. 723-7
45. Tanabe, A., M. Naruse, K. Naruse, M. Hase, T. Yoshimoto, M. Tanaka, T. Seki, R. Demura, and H. Demura, Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res, 1997. 20(2): p. 85-90
46. Savard, S., L. Amar, P.F. Plouin, and O. Steichen, Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study. Hypertension, 2013
47. Villari, B., G. Vassalli, E.S. Monrad, M. Chiariello, M. Turina, and O.M. Hess, Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation, 1995. 91(9): p. 2353-8
48. Lorell, B.H. and B.A. Carabello, Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation, 2000. 102(4): p. 470-9
49. Catena, C., G. Colussi, L. Marzano, and L.A. Sechi, Aldosterone and the heart: from basic research to clinical evidence. Horm Metab Res, 2012. 44(3): p. 181-7
50. Widimsky, J., Jr., B. Strauch, O. Petrak, J. Rosa, Z. Somloova, T. Zelinka, and R. Holaj, Vascular disturbances in primary aldosteronism: clinical evidence. Kidney Blood Press Res, 2012. 35(6): p. 529-33